Kopran's Evaluation Score Adjusted Amidst Ongoing Financial Challenges and Mixed Performance
Kopran, a microcap in the Pharmaceuticals & Biotechnology sector, has recently adjusted its evaluation score, reflecting a shift in technical trends. Despite a 10.07% return over the past week, the company has faced significant challenges, including negative results for four consecutive quarters and a year-to-date decline of 19.05%.
Kopran, a microcap player in the Pharmaceuticals & Biotechnology sector, has recently undergone an adjustment in its evaluation score. This revision reflects a shift in technical trends, indicating a transition from a bearish outlook to a mildly bearish stance. The stock's performance metrics reveal a complex picture. Over the past week, Kopran has shown a return of 10.07%, contrasting with a slight decline in the Sensex. However, the year-to-date performance indicates a decline of 19.05%, and the stock has faced significant challenges over the past year, with a return of -43.79%.
Financially, the company has reported negative results for four consecutive quarters, with a notable decline in net sales of 3.03% in June 2025. The latest six-month period shows a PAT of Rs 17.13 crore, reflecting a decrease of 42.36%. Despite these challenges, Kopran maintains a low Debt to EBITDA ratio of 1.00 times, suggesting a strong ability to service its debt.
Overall, the adjustment in Kopran's evaluation score highlights the ongoing complexities in its financial landscape.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
